Douglas J. Rhee, MD

B. OCULAR DECONGESTANTSDrug Trade Preparation Usual Dose Notesnaphazoline All Clear, Allergy Drops , Soln, 0.012% QID PRN Alpha agonistDigest 2 , NaphconAll Clear AR, Comfort Soln, 0.03% QID PRNEye DropsAK-Con, Napha-Forte, Soln, 0.1% QID PRNNaphcon Forte, Nafazair,VasoconOpcon Max. Strength, Soln, 0.3% QID PRNAllergy Dropsnaphazoline /glycerin Clear Eyes Soln, 0.012%/0.2% QID PRN Alpha agonist/artificial tearnaphazoline /polyvinyl Albalon Soln, 0.1%/1.4% QID PRN Alpha agonist/artificial tearalcohol Vasoclear Soln, 0.02%/2.5%naphazoline /polyvinyl Vasoclear A Soln, 0.02%/2.5% QID PRN Alpha agonist/art. tear/alcohol/zinc sulfate astringent 1naphazoline /glycerin/ Clear Eyes ACR Soln, 0.012%/0.2%/0.25% QID PRN Alpha agonist/art. tear/zinc sulfate astringent 1naphazoline /pheiramine Naphcon -A, Napha-A, Soln, 0.025%/0.3% QID PRN Alpha agonist/antihistamineOcuHist, Visine-Anaphazoline /antazoline Vasocon -A Soln, 0.05%/0.5% QID PRN Alpha agonist/antihistamineoxymetazoline Ocuclear, Visine LR Soln, 0.025% QID PRN Alpha agonistphenylephrine AK-Nefrin , Ocu-phrin Soln, 0.12% QID PRN Alpha agonist(continued)Miscellaneous Conditions 95